Although published reports involving the role of DHODH-mediated CoQH2 generation in PD remain limited, the use of CoQ10 supplementation in patients with PD has demonstrated safety and patient tolerance, achieving phase 2/3 trials. This evidence concerns the gene DHODH and Parkinson disease.